Cargando…
Male mammary gland development after apatinib therapy in advanced gastric cancer: A case report
RATIONALE: Most gastric cancer patients are diagnosed at mid- to late-stage and lose the chance of radical surgery, medical treatment is especially important to prolong the survival of patients. Apatinib mesylate, which is a small molecule vascular endothelial growth factor receptor 2 tyrosine kinas...
Autores principales: | Hui, Yan, Wang, Jingchun, Han, Jianguo, Guo, Zhifeng, Sun, Siqi, Wu, Zifang, Wang, Yanqiu, Han, Zhimin, Chen, Xiangbin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7360214/ https://www.ncbi.nlm.nih.gov/pubmed/32664067 http://dx.doi.org/10.1097/MD.0000000000020727 |
Ejemplares similares
-
Apatinib combined with S-1 as second-line therapy in advanced gastric cancer
por: Qiu, Zhi-Yuan, et al.
Publicado: (2021) -
Careful dose modification of apatinib as third or further-line treatment in advanced gastric cancer patients with poor performance status
por: Chen, Jianxin, et al.
Publicado: (2019) -
A case report of targeted therapy with apatinib in a patient with advanced gastric cancer and high serum level of alpha-fetoprotein
por: Zhu, Xue-Ru, et al.
Publicado: (2016) -
Apatinib concurrent gemcitabine for controlling malignant ascites in advanced pancreatic cancer patient: A case report
por: Liang, Lijun, et al.
Publicado: (2017) -
A Case Report of Gastrointestinal Hemorrhage and Perforation During Apatinib Treatment of Gastric Cancer
por: Li, Xiao-Fen, et al.
Publicado: (2015)